What ICD‑10‑CM diagnosis code should be assigned for a patient who started cocaine use 20 days to 1.5 months ago, now uses cocaine 5–6 times daily, uses flakka (a synthetic stimulant) daily, intermittently uses kratom and unspecified psychoactive substances, and presents with depressive symptoms, anxiety, cravings, functional impairment, and no suicidal or homicidal ideation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

ICD-10-CM Diagnosis Code: F14.20

The primary diagnosis code for this patient is F14.20 (Cocaine dependence, uncomplicated), with additional codes F15.20 (Other stimulant dependence, uncomplicated) for flakka use and F55.8 (Abuse of other non-psychoactive substances) for kratom use.

Rationale for Primary Code Selection

This patient meets clear criteria for severe cocaine use disorder based on DSM-5 criteria 1:

  • Tolerance and escalation: Progressed from social use to 5-6 times daily within 20-30 days
  • Loss of control: Using "to stay normal" rather than for desired effects
  • Craving: Reports persistent cravings and obsessive thoughts about cocaine
  • Functional impairment: Missing work, calling out sick from employment
  • Continued use despite consequences: Spending >$2,000 in 20 days despite financial strain
  • Withdrawal symptoms: Depression, anxiety, and racing thoughts when not using

The "uncomplicated" specifier (F14.20) is appropriate because the patient denies suicidal ideation, homicidal ideation, or hallucinations, and the depressive/anxiety symptoms appear to be substance-induced rather than meeting full criteria for an independent mood or anxiety disorder 1.

Additional Required Codes

Flakka (Synthetic Cathinone) Use

F15.20 (Other stimulant dependence, uncomplicated) is the appropriate code for daily flakka use. Flakka (alpha-PVP) is a synthetic cathinone classified under "other stimulants" in ICD-10-CM. The daily use pattern with cocaine suggests polysubstance dependence.

Kratom Use

F55.8 (Abuse of other non-psychoactive substances) applies to kratom, which is not classified as a controlled substance in ICD-10-CM but is used 1-2 times weekly. While kratom has opioid-like properties 2, 3, the intermittent use pattern (once or twice weekly for 6 months) does not meet dependence criteria. F55.8 is the most accurate code for non-dependent kratom use 4.

"Pseudopills" (Unspecified Psychoactive Substances)

F19.10 (Other psychoactive substance abuse, uncomplicated) should be added if the "pseudopills" represent intermittent use of unidentified substances that don't meet dependence criteria.

Substance-Induced Mental Disorder Considerations

The depressive symptoms, anxiety, and racing thoughts described are best conceptualized as substance-induced rather than independent disorders 1. Key factors:

  • Symptoms occur during active cocaine use and when not using (withdrawal)
  • Timeline suggests symptoms emerged after cocaine initiation
  • Cocaine is pharmacologically capable of producing these psychiatric symptoms 1
  • No evidence symptoms persisted >4 weeks after cessation (patient is actively using)

Do not code a separate depressive or anxiety disorder at this time. If symptoms persist >4 weeks after achieving abstinence, reassess for independent mood/anxiety disorders 1.

Coding Pitfalls to Avoid

  1. Do not use F14.10 (Cocaine abuse, uncomplicated): This patient clearly meets criteria for dependence/severe use disorder, not abuse/mild use disorder. The rapid escalation, daily use 5-6 times, functional impairment, and craving indicate severe disorder 5.

  2. Do not code F14.23 (Cocaine dependence with withdrawal): While the patient experiences withdrawal symptoms (depression, anxiety when not using), this code is reserved for acute withdrawal states requiring medical management, not ongoing use with inter-dose withdrawal 1.

  3. Avoid F14.99 (Cocaine use, unspecified): Research shows this code is often misapplied and creates diagnostic ambiguity 6, 5. The clinical picture clearly supports a dependence diagnosis.

  4. Do not code separate anxiety or depressive disorders: These symptoms are substance-induced and should not receive independent diagnostic codes until proven to persist after sustained abstinence 1.

Complete Diagnostic Code Set

Primary diagnosis:

  • F14.20 (Cocaine dependence, uncomplicated)

Secondary diagnoses:

  • F15.20 (Other stimulant dependence, uncomplicated) [for flakka]
  • F55.8 (Abuse of other non-psychoactive substances) [for kratom]
  • F19.10 (Other psychoactive substance abuse, uncomplicated) [for "pseudopills" if intermittent use]

Additional symptom codes (optional for documentation):

  • R06.02 (Shortness of breath) [if diaphoresis/tachycardia warrant documentation]
  • R51.9 (Headache, unspecified) [if nasal irritation is significant]

The evidence shows that ICD-10-CM codes have high specificity but low sensitivity for detecting substance use 6, meaning accurate coding is critical for treatment planning, insurance authorization, and continuity of care. This coding approach captures the polysubstance use pattern while prioritizing the most severe and clinically significant disorder (cocaine dependence).

References

2
Research

The neuropharmacology of kratom, a novel psychoactive natural product.

Progress in neuro-psychopharmacology & biological psychiatry, 2025

Related Questions

What ICD-10-CM diagnosis code should be used for a patient with attention-deficit hyperactivity disorder, obsessive-compulsive disorder, anxiety, and insomnia when requesting prior authorization for doxepin 3 mg?
What is the appropriate ICD‑10‑CM code for attention‑deficit/hyperactivity disorder in an adult with racing thoughts?
What ICD‑10‑CM diagnostic codes, other than screening codes, can be used for a Pap smear performed as part of the pre‑egg donation work‑up in a 19‑year‑old woman?
What ICD-10-CM diagnosis codes correspond to social isolation?
What are the ICD‑10‑CM diagnosis codes for Attention‑Deficit/Hyperactivity Disorder (ADHD) and the ICD‑9‑CM code?
For how many months can montelukast be used as maintenance therapy for bronchial asthma?
I recently started sertraline (Zoloft) and am experiencing strange sensations; what are the typical early side effects and when should I seek medical attention?
What is the correct dose of Augmentin (amoxicillin/clavulanate) suspension (400 mg/57 mg per 5 mL) for an 8‑year‑old child weighing 89 lb (≈40 kg)?
What is the clinical relevance of the spinothalamic tracts and posterior columns in diagnosing and managing spinal cord or peripheral nervous system injuries?
Can hydroxyzine help with activation symptoms from sertraline (Zoloft)?
How long do activation symptoms from Zoloft (sertraline) persist after reducing the dose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.